A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (Mc4) is more useful in differentiation of graves' disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells

Thyroid

Volumn 20, Issue 8, 2010, Pages 851-856

  Kamijo, Keiichi ^a   Murayama, Hiroshi ^b   Uzu, Takahiro ^b   Togashi, Kazuyoshi ^b   Kahaly, George J ^c  

^a Kamijo Thyroid Research Institute   (Japan)

^b YAMASA CORPORATION   (Japan)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; ANIMAL CELL; ARTICLE; BIOASSAY; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INTERMETHOD COMPARISON; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; SUBACUTE THYROIDITIS; SWINE; THYROID CELL;

ADULT; ANIMALS; BIOLOGICAL ASSAY; CHO CELLS; CHORIONIC GONADOTROPIN; CRICETINAE; CRICETULUS; FEMALE; GENES, REPORTER; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; LUTEINIZING HORMONE; MALE; RATS; RECEPTORS, THYROTROPIN; SWINE; THYROID GLAND; THYROIDITIS, SUBACUTE;

EID: 77955288853     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0059     Document Type: Article

References (14)

1. Adams DD, Knight A, Knight JG, Laing P 1987 Graves disease: a paradigm for autoimmunity. In: Pinchera A, Ingbar SH, McKenzie JM, Fenzi GF (eds) Thyroid Autoimmunity. Plenum Press, New York, pp 1-10.
2. Kohn LD, Kosugi S, Ban T, Saji M, Ikuyama S, Giuliani C, Hidaka A, Shimura H, Akamizu T, Tahara K, Moriarty J, Prabhakar BS, Singer DS 1992 Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int Rev Immunol 9:135-165.
3. Kohn LD, Giuliani C, Montani V, Napolitano G, Ohmori M, Ohta M 1995 Antireceptor immunity. In: Rayner D, Champion B (eds) Thyroid Immunity. RG Landes Biomedical Publishers, Austin/Georgetown, TX, pp 115-170.
4. Akamizu T 2001 Antithyrotropin receptor antibody: an update. Thyroid 11:1123-1134.
5. Cho BY 2002 Clinical application of TSH receptor antibodies in thyroid diseases. J Korean Med Sci 17:293-301.
6. Smith BR, Sanders J, Furmaniak J 2007 TSH receptor antibodies. Thyroid 17:923-938.
7. McIntosh RS, Asghar MS, Weetman AP 1997 The antibody response in human autoimmune thyroid disease. Clin Sci 92:529-541.
8. Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N 1997 Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild types or chimeric human TSH receptor. Thyroid 7:13-20.
9. Grasso YZ, Kim MR, Faiman C, Kohn LD, Tahara K, Gupta MK 1999 Epitope heterogeneity of thyrotropin receptorblocking antibodies in graves patients as detected with wild-type versus chimeric thyrotropin receptor. Thyroid 9:531-537.
10. Rakover Y, Sadeh O, Sobel E, Shneyour A, Kraiem Z 1990A case of transient hypothyroidism: sequential serum measurements of autoantibodies inhibiting thyrotropin-stimulated thyroid cAMP production in a neonate. Acta Endcrinol 123: 118-122.
11. Ueda Y, Sugawa H, Akamizu T, Okuda J, Ueda M, Kosugi S, Ohta C, Kihou Y, Mori T 1995 Thyroid stimulating antibodies in sera from patients with graves disease are heterogeneous in epitope recognition. Eur J Endcrinol 132:62-68.
12. Tahara K, Ban T, Minegishi T, Kohn LD 1991 Immunoglobulins from Graves disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 1179:70-77.
13. Kamijo K, Nagata A, Sato Y 1999 Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves disease using polyethylene glycol at high concentrations and porcine thyroid cells. Endocr J 46:397-403.
14. Kohn LD, Harii N 2003 Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance. Autoimmunity 36:331-337.